Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lineage Cell Therapeutics (LCTX) Long-Term Deferred Tax: 2016-2020

  • Lineage Cell Therapeutics' Long-Term Deferred Tax rose 10.15% to $62.0 million in Q4 2020 from the same period last year, while for Dec 2020 it was $62.0 million, marking a year-over-year increase of 10.15%. This contributed to the annual value of $62.0 million for FY2020, which is 10.15% up from last year.
  • Per Lineage Cell Therapeutics' latest filing, its Long-Term Deferred Tax stood at $62.0 million for Q4 2020, which was up 10.15% from $56.3 million recorded in Q4 2019.
  • Lineage Cell Therapeutics' 5-year Long-Term Deferred Tax high stood at $62.0 million for Q4 2020, and its period low was $49,213 during Q4 2016.
  • For the 3-year period, Lineage Cell Therapeutics' Long-Term Deferred Tax averaged around $52.3 million, with its median value being $56.3 million (2019).
  • As far as peak fluctuations go, Lineage Cell Therapeutics' Long-Term Deferred Tax soared by 82,489.97% in 2017, and later decreased by 5.24% in 2018.
  • Lineage Cell Therapeutics' Long-Term Deferred Tax (Quarterly) stood at $49,213 in 2016, then skyrocketed by 82,489.97% to $40.6 million in 2017, then decreased by 5.24% to $38.5 million in 2018, then spiked by 46.12% to $56.3 million in 2019, then grew by 10.15% to $62.0 million in 2020.
  • Its Long-Term Deferred Tax stands at $62.0 million for Q4 2020, versus $56.3 million for Q4 2019 and $38.5 million for Q4 2018.